[go: up one dir, main page]

WO2008066350A1 - Ditpase et gènes le codant - Google Patents

Ditpase et gènes le codant Download PDF

Info

Publication number
WO2008066350A1
WO2008066350A1 PCT/KR2007/006150 KR2007006150W WO2008066350A1 WO 2008066350 A1 WO2008066350 A1 WO 2008066350A1 KR 2007006150 W KR2007006150 W KR 2007006150W WO 2008066350 A1 WO2008066350 A1 WO 2008066350A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
dna
dna polymerase
ditpase
ditp
Prior art date
Application number
PCT/KR2007/006150
Other languages
English (en)
Inventor
Jung Hyun Lee
Sung Gyun Kang
Sang Jin Kim
Kae Kyoung Kwon
Hyun Sook Lee
Yun Jae Kim
Yong Gu Ryu
Seung Seob Bae
Jae Kyu Lim
Jung Ho Jeon
Yo Na Cho
Insoon Jeong
Suk Tae Kwon
Sun Shin Cha
Original Assignee
Korea Ocean Research & Development Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Ocean Research & Development Institute filed Critical Korea Ocean Research & Development Institute
Publication of WO2008066350A1 publication Critical patent/WO2008066350A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria

Definitions

  • the present invention relates to a novel dITPase, protein for enhancing DNA polymerase activity, and genes encoding it.
  • thermostable DNA polymerase which uses the thermostable DNA polymerase, is one of the most important contributions to protein and genetic research and is current Ly used in a broad array of biological applications. More than 50 DNA polymerase genes have been cloned from various organisms, including thermophiles and archaeas . Recently, family B DNA polymerases from hyperthermophilic archaea, Pyrococcus and Thermococcus, have been widely used since they have higher fidelity in PCR based on their proof reading activity than Taq polymerase commonly used. However, the improvement of the high fidelity enzyme has been on demand due to lower DNA elongation ability. [Background Art]
  • the present inventors isolated a new hyperthermophilic strain from a deep-sea hydrothermal vent area at the PACMANUS field. It was identified as a member of Thermococcus based on 16S rDNA sequence analysis, and the whole genome sequencing is currently in process to search for many extremely thermostable enzymes. The analysis of the genome information displayed that the strain possessed a family B type DNA polymerase. The present inventors cloned the gene corresponding to the DNA polymerase and expressed in E. coli. In addition, the recombinant enzyme was purified and its enzymatic characteristics were examined. Therefore, the present inventors applied for a patent on the DNA polymerase having high DNA elongation and high fidelity ability (Korean Patent Application No.
  • the present inventors isolated a HAM-I like protein from Thermococcus sp. and identified as a novel dITPase enhancing DNA polymerase proce ⁇ ssivity when it is used with DNA polymerase together.
  • the HAM-I like protein can be used for all of reactions of DNA polymerization.
  • the present inventors found that the protein according to the present invention can be used for reactions of DNA polymerization which is demanded for high sensitivity £ind rapidity, because it has a property of supporting DNA polymerase activity, thereby completing the present invention.
  • the present invention provides a dITPase protein and their functional equivalents. More specifically, the present invention provides dITPase protein and their functional equivalents, wherein the protein has the activity of enhancing DNA polymerase processivity.
  • the dITPase protein according to the present invention is the protein of SEQ ID NO: 1, and specifically, "functional equivalent" includes a protein for enhancing DNA polymerase activity having amino acids sequence shown in SEQ ID NO: 1, or amino acid sequence variants having amino acid substitutions in some or all of the protein for enhancing DNA polymerase, or amino acid additions or deletions in some of the protein for enhancing DNA polymerase.
  • the present invention includes the protein synthesized in vitro from public amino acids sequence .
  • the present invention provides a nucleotide sequence encoding the protein of SEQ ID NO: 1.
  • the nucleotide sequence is SEQ ID NO: 2.
  • nucleotide sequences encoding the protein of SEQ ID NO: 1 can be prepared diversely.
  • the present invention provides a recombinant vector comprising the gene of SEQ ID NO: 2.
  • vector means a nucleic acid molecule that can carry another nucleic acid bound thereto.
  • expression vector is intended to include a plasmid, cosmid or phage, which can synthesize a protein encoded by a recombinant gene carried by said vector.
  • a preferred vector is a vector that can self-replicate and express a nucleic acid bound thereto.
  • the present invention provides a host cell transformed with said recombinant vector.
  • transformation means that foreign DNA or RNA is absorbed into cells to change the genotype of the cells.
  • the present invention provides a method for producing the protein of SEQ ID NO: 1 by using said host cell.
  • Optional recombinant proteins for expression include human proteins, and mean all proteins to use for treating diseases, or to be applicable industrially.
  • the present invention provides a specific antibody against the protein of SEQ ID NO: 1, wherein the specific antibody is prepared by injecting the protein of SEQ ID NO: 1.
  • the present invention provides a method for enhancing DNA polymerization with the DNA polymerase by using said protein.
  • DNA polymerase refers to an enzyme that synthesizes DNA in the 5' -> 3' direction from deoxynucleotide triphosphate using a complementary template DNA strand and a primer by successively adding nucleotide to a free 3'-hydroxyl group.
  • the template strand determines the sequence of the added nucleotide by Watson- Crick base pairing.
  • PCR Polymerase Chain Reaction
  • a target DNA can be amplified more effectively.
  • the mixing of the protein of SEQ ID NO: 1 and a DNA polymerase can be simultaneously or differentially. That is one method is that mixture of the protein of SEQ ID NO: 1 and a DNA polymerase are added to PCR reaction solution, and then PCR reaction can be performed by adding target DNA fragment, and one another method is that target DNA are added to premix solution including a DNA polymerase, and then PCR reaction can be performed by adding the protein of SEQ ID NO: 1. [Advantageous Effects]
  • the dITPase, a HAM-I like protein, according to the present invention enhances DNA polymerase processivity when it is used with DNA polymerase together. Accordingly, the HAM-I like protein can be used for all reactions of DNA polymerization. Especially, the dITPase according to the present invention can be used for reactions of DNA polymerization which was demanded for high sensitivity and rapidity, because it has a property of supporting DNA polymerase activity. In this case, we identified the PCR reaction with dITPase and dUTPase together is more efficient (Fig. 12) .
  • FIG. 1 shows sequence alignments of TNAl HAM-I with other HAM-I like genes and dNTPase pyrophosphatase.
  • FIG. 2 shows the results of SDS-PAGE analysis of the recombinant Hisg-tagged TNAl HAM-I.
  • Lane 1 low molecular range standard (Bio-Rad) ;
  • Lane 2 TNAl HAM-I purified by His-tagged affinity chromatography.
  • FIG. 3 shows effect of dITP on PCR amplification with various DNA polymerases.
  • A PCR amplification by rTaq and TNAl DNA polymerase with various concentrations of dITP (0, 0.025, 0.05, 0.1, 0.2mM);
  • B PCR amplification by various DNA polymerases with dITP (0.05mM dITP) and without dlTP (dITP X) .
  • FIG. 4 shows effect of TNAl HAM-I on E 3 CR amplification with various DNA polymerases.
  • FIG. 5 shows a cleavage map of recombinant plasmid according to the present invention.
  • FIG. 6 shows effect of dITP on PCR amplification by family A and B type DNA polymerases .
  • a 2 kb target from ⁇ DNA was amplified using 2.5 units of rTaq (Takara) or ].5 units of various family B-type DNA polymerases .
  • the reaction mixture contain 5 ng of ⁇ DNA, 10 pmol of primers, 0.25 UiM dNTPs, 0.05 mM dITP, and PCR reaction buffer.
  • FIG. 7 shows multi-alignment of the uracil-sensing domain of archaeal family B-type DNA polymerases from Pyrococcus and Thermococcus genus .
  • the amino acid sequence accession numbers are Pyrococcus horikoshii (059610) , P. abyssi (P77916) , P. glycovorans (CAC12849) , Pyrococcus sp. GE23 (CAA90887), Pyrococcus sp. GB-D (Q51334), P. furiosus (P61875) , P. woesei (P61876) , Thermococcus kodakaraensis
  • FIG. 8 shows primer extension assays using various archaeal family B-type DNA polymerases . Templates containing a single uracil (A) , or two successive uracils (B) were used. The first and second lanes in each panel exhibit 23-mer primer and 44-mer template, respectively.
  • FIG. 9 shows primer extension assays using TNAl DNA polymerase in the presence of hypoxanthine .
  • Templates containing no deaminated base (A) , two successive uracils (B) , or two successive hypoxanthines (C) were used.
  • the first and second lanes exhibit 23-mer primer and 44-mer template, respectively.
  • D PCR amplification using wild- type and mutant of TNAl DNA polymerases in the presence of dITP.
  • the reaction mixture contained 5 ng of ⁇ DNA, 10 pmol of primers, 0.25 mM dNTPs, 0.025 mM dITP, and PCR reaction buffer.
  • FIG. 10 shows whole domain swapping experiments.
  • A Schematic representation of Pfu and TNAl fusion proteins. The numbers indicate the residues of NAl.
  • B and C primer extension assays using Pfu and TNAl fusion proteins show the recognition of uracil. Templates containing a single uracil (B) or two successive uracils (C) were used. The first lane shows 23-mer primer and 44-mer template, respectively.
  • FIG. 11 shows primer extension assays using Pfu, TNAl, and KODl DNA polymerases. Templates containing a single uracil were used. The first and second lanes exhibit 23-mer primer and 44-mer template, respectively.
  • FIG. 12 shows effect of dITPase on PCR amplification. PCR was performed with TNAl (A) or Pfu DNA polymerases (B) in the presence of dITPase and dUTPase. The reaction mixture contained 5 ng of ⁇ DNA, 10 pmol of primers, 0.35 mM dNTPs, 5 ng dITPase or dUTPase, and PCR reaction buffer.
  • FIG. 13 shows dITP incorporation assay using PEu, KODl and TNAl family B-type DNA polymerases.
  • the reaction mixture contained primer-template complexs (200 fmol), 1.25 units of TNAl, 50 mM Tris-HCl pH 8.5, 60 mM KCl, 30 mM (NH 4 ) 2 SO 4 , 1 mM MgCl 2 , and only 0.1 mM dITP.
  • FIG. 14 shows primer extension assays using Pfu DNA polymerase.
  • FIG. 15 shows superimposed uracil-sensing domains and molecular docking of hypoxanthine. C ⁇ -tracing of superposed uracil-sensing domains of 0.313 A RSMD from KODl DNA polymerase (red; PDB code, IWNS) and Pfu DNA polymerase
  • FIG. 16 shows primer extension assays using various archaeal family B-type DNA polymerases .
  • Templates containing no deaminated base (A) , a single xanthine (B) , two successive xanthines (C) and four successive xanthines (D) were used.
  • the first and second lanes in each panel exhibit 23-mer primer and 44-mer template, respectively.
  • FIG. 17 shows optimal conditions of the nucleotide hydrolysis activities of dITPase.
  • FIG. 18 shows dynamic effect on hydrolysis of nucleotide triphosphate by dITPase and dUTPase.
  • the present invention provides a dITPase protein and their functional equivalents . More specifically, the present invention provides dITPase protein and their functional equivalents having the activity of enhancing DNA polymerase processivity.
  • the dITPase protein according to the present invention is the protein of SEQ ID NO: 1, and specifically, "functional equivalent" includes a protein for enhancing DNA polymerase activity having amino acids sequence shown in SEQ ID NO: 1, or amino acid sequence variants having amino acid substitutions in some or all of the protein for enhancing DNA polymerase, or amino acid additions or deletions in some of the protein for enhancing DNA polymerase.
  • the present invention includes the protein synthesized in vitro from public amino acids sequence.
  • the present invention includes the purified protein comprising amino acids sequence with greater than 55% similarity to amino acids sequence shown in SEQ ID NO: 1.
  • the peptides have greater than 60% sequence similarity. More preferably, the peptides have greater than 70% sequence similarity. Most preferably, the peptides have greater than 80% sequence similarity.
  • amino acids sequence with more than 55% similarity means at least 55% identical or conservatively replaced amino acid residues in a like position when aligned optimally allowing for up to 4 gaps with the proviso that in respect of each gap a total not more than 10 amino acid residues is affected.
  • the amino acid substitutions are preferably conservative substitutions.
  • conservative substitutions of naturally occurring amino acids include aliphatic amino acids (GIy, Ala, and Pro) , hydrophobic amino acids (lie, Leu, and VaI) , aromatic amino acids (Phe, Tyr, and Trp) , acidic amino acids (Asp, and GIu) , basic amino acids (His, Lys, Arg, GIn, and Asn) , and sulfur- containing amino acids (Cys, and Met) .
  • the deletions of amino acids are located in a region which is not involved directly in enhancing the activity of DNA polymerization.
  • the present invention provides a nucleotide sequence encoding the protein of SEQ ID NO: 1. Specifically, the nucleotide sequence is SEQ ID NO: 2.
  • nucleotide sequences encoding the protein of SEQ ID NO: 1 can be prepared diversely.
  • nucleic acid sequence is intended to include natural mRNA identified selective expression, complementary DNA (cDNA) sequence and equivalent nucleic acid sequence thereof.
  • equivalent nucleic acid sequence is intended to include sequences provided herein, sequences with allelic variation and with variation between species, or degenerate codon sequence.
  • the term “degenerate codon sequence” refers to a nucleic acid sequence, which is different from said naturally occurring sequence, but encodes a polypeptide having the same sequence as that of the polypeptide of SEQ ID NO: 1 disclosed in the present invention.
  • sequences with allelic variation or “a sequence wit h variation between species” refers to a nucleic acid sequence, which is different from said naturally occurring nucleic acid sequence, but encodes a polypeptide having practically the same functional feature as that of said polypeptide disclosed herein.
  • the present invention provides a recombinant vector comprising the gene of SEQ ID NO: 2.
  • vector means a nucleic acid molecule that can carry another nucleic acid bound thereto.
  • expression vector is intended to include a plasmid, cosmid or phage, which can synthesize a protein encoded by a recombinant gene carried by said vector.
  • a preferred vector is a vector that can self-replicate and express a nucleic acid bound thereto.
  • the present invention provides a host cell transformed with said recombinant vector.
  • transformation means that foreign DNA or RNA is absorbed into cells to change the genotype of the cells.
  • Host cells suitable for transformation include prokaryotic, fungal, plant and animal cells, but are not limited thereto. Most preferably, E. coli cells are used. Methods for culturing E. coli are well known in the art.
  • the present invention provides a method for producing the protein of SEQ ID NO: 1 using said host cell.
  • Optional recombinant proteins for expression include human proteins, and mean all proteins to use for treating diseases, or to be applicable industrially.
  • the present invention provides a specific antibody against the protein of SEQ ID NO: 1, wherein the specific antibody is prepared by injecting the protein of SEQ ID NO: 1.
  • the present invention provides a method for enhancing DNA polymerization with the DNA polymerase by using said protein.
  • DNA polymerase refers to an enzyme that synthesizes DNA m the 5' -> 3' direction from deoxynucleotide triphosphate using a complementary template DNA strand and a primer by successively adding nucleotide to a free 3'-hydroxyl group.
  • the template strand determines the sequence of the added nucleotide by Watson-Crick base pairing.
  • a target DNA can be amplified more efficiently.
  • the method of mixing of the protein of SEQ ID NO: 1 and a DNA polymerase can be simultaneously or differentially. That is one method is that mixture of the protein of SEQ ID NO: 1 and a DNA polymerase are added to PCR reaction solution, and then PCR reaction can be performed by adding target DNA fragment, and one another method is that target DNA are added to premix solution including a DNA polymerase, and then PCR reaction can be performed by adding the protein of SEQ ID NO: 1.
  • Thermococcus sp. NAl was isolated from a deep-sea hydrothermal vent area in the East Manus Basin. YPS medium was used to culture Thermococcus sp. NAl for DNA manipulation. Culture and strain maintenance were performed according to standard procedures. To prepare a seed culture of Thermococcus sp. NAl, YPS medium in a 25-ml serum bottle was inoculated with a single colony from a phytagel plate and cultured at 90 0 C for 20 h. Seed cultures were used to inoculate 700 ml of YPS medium in an anaerobic jar and cultured at 90°C for 2O h. E.
  • E. coli strain DH5 ⁇ was used for plasmid propagation and nucleotide sequencing.
  • E. coli strain BL21-CodonPlus (DE3) -RIL cells (Stratagene, LaJoIIa, CA) and the plasmid pET-24a(+) (Novagen, Madison, WI) were used for gene expression.
  • E. coli strains were cultivated in Luria-Bertani medium with 50 ⁇ g/ml kanamycin at 37°C.
  • DNA manipulation and sequencing DNA manipulations were performed using standard procedures, as described by Sambrook and Russell [Sambrook, J. & Russell, D. W., Molecular cloning: a laboratory manual, 3 rd ed., Cold Spring Harbor, N. Y. (2001)]. Genomic DNA of Thermococcus sp. NAl was isolated using a standard procedure. Restriction enzymes and other modifying enzymes were purchased from Promega (Madison, WI) . Small-scale preparation of plasmid DNA from E. coli cells was performed
  • DNA sequencing was performed using an ABI3100 automated sequencer, using a BigDye terminator kit (PE Applied Biosystems, Foster City, CA) .
  • TNAl HAM-I encoding gene The full length of Thermococcus sp. NAl HAM-I gene flanked by Ndel and Xhol sites was amplified by PCR using two primers and genomic DNA as a template.
  • the amplified fragment was digested with Ndel and Xhol, and ligated with pET-24a(+) digested with Ndel/Xhol.
  • the ligate was transformed into E. coli DH5 ⁇ .
  • the resulting plasmid was transformed into E. coli BL21-CodonPlus (DE3) - RIL and E. coli Rosetta (DE3) pLysS strain, respectively.
  • IPTG isopropyl- ⁇ -D-thiogalactopyranoside
  • the cells were harvested by centrifugation (6000 x g at 4 ° C for 20 min) and resuspended in 50 mM Tris-HCl buffer (pH 8.0) containing 0.1 M KCl and 10% glycerol. The cells were disrupted by sonication and harvested by centrifugation (20,000 x g at 4 ° C for 30 min). The resulting supernatant
  • the concentrations of proteins were determined by the colorimetric assay of Bradford (1976) .
  • the purification degrees of the proteins were examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis according to a standard method (Laemmli, 1970) .
  • the TNAl HAM-I gene amplified by PCR was cloned into pET-24a(+) and transformed into E. coli BL21- CodonPlus (DE3)-RIL, and then expressed.
  • E. coli BL21- CodonPlus (DE3)-RIL
  • SDS-PAGE analysis the 95% purified enzyme revealed a single protein band with a molecular mass of 21 kDa, which was deduced amino acid sequence (FIG. 2).
  • TNAl HAM-I protein and a high fidelity DNA polymerase.
  • 50 ng of TNAl HAM-I protein was added to PCR mixture with various high fidelity DNA polymerases, respectively.
  • PCR mixture was consisted of 2.5U of DNA polymerase, 150 ng of genomic DNA from Thermococcus sp. NAl as a template, 10 pmole of each primer, 200 ⁇ M dNTPs and PCR reaction buffer.
  • Thermococcus sp. NAl, primers were designed (Table 1).
  • dITP dITP was automatically generated by deamination of dATP on PCR amplification and considered to be mainly responsible for decreasing PCR efficiency.
  • effects of TNAl HAM-I in addition to PCR reaction with high fidelity DNA polymerase were examined.
  • PCR reaction with high fidelity DNA polymerase in presence of TNAl HAM-I protein could be amplified a target DNA more effectively than in absence of TNAl HAM-I protein. It was expected that elimination of dITP by TNAl HAM-I protein in PCR reaction solution would be more effective in PCR amplification due to inhibition of stalling .
  • Plasmids were transformed Into Escherichia coli BL21 Rosetta (DE3)pLysS. Overexpression of genes was induced by addition of isopropyl- ⁇ - D -thiogalactopyranoside (IPTG) at the mid-exponential growth phase, followed by additional 3 h incubation at 37 0 C. Cells were then, harvested by centrifugation (6000 x g at 4 °C for 20 min) , and resuspended in 50 mM Tris-HCl buffer (pH 8.0) containing 0.1 M KCl and 10% glycerol, followed by sonication.
  • IPTG isopropyl- ⁇ - D -thiogalactopyranoside
  • the cell lysate was centrifuged (20,000 x g at 4 0 C for 30 min), and crude samples were prepared by heat treatment at 80 0 C for 20 min.
  • the resulting supernatant was applied to a column of TALON metal affinity resin (BD Biosciences, Clontech, Palo Alto, CA) and washed with 10 mM imidazole (Sigma, St. Louis, MO) in 50 mM Tris-HCl buffer (pH 8.0) containing 0.1 M KCl and 10% glycerol, and the protein was eluted with 300 mM imidazole in the same buffer.
  • the pooled fractions were dialyzed in storage buffer containing 50 mM Tris-HCl (pH 7.5), 1 mM DTT, 1 mM EDTA, and 10% glycerol.
  • Primer extension assay was performed as described by Fogg et al. with slight modification (Fogg MJ, Pearl LH, Connolly BA, 2002, Nature Struct Biol 9:922-927). In brief, templates (Table 3) containing uracil, hypoxanthine or xanthine were used.
  • the primer-template complex (400 fmol) was incubated at 75 0 C for 15 min with 1.25 units of TNAl DNA polymerase in 120 mM Tris-HCl (pH 8.8), 60 inM KCl, 30 mM (NH 4 ) 2 SO 4 , 1 mM MgCl 2 , and 0.25 mM of each dNTP.
  • the reaction mixtures for rTaq (Takara) , Pfu (Promega) , Deep-vent (New England Biolabs, Inc., Beverly, Mass), Vent (New England Biolabs, Inc., Beverly, Mass), and KODl (Novagen) DNA polymerases were slightly modified using each manufacturer's buffer. After incubation, each sample was analyzed by 15% polyacrylamide gel electrophoresis followed by autoradiography.
  • TNAl DNA polymerase buffer consisted of 120 mM Tris-HCl (pH 8.8), 30 mM (NH 4 J 2 SO 4 , 60 mM KCl, and 1 mM MgCl 2 After single 1 min denaturation step at 95 °C, 30 cycles of denaturation (20 sec at 94 0 C) , annealing and extension (2 kb, 2 min; 5 kb, 3.5 min; 8 kb, 5 min; 10 kb,
  • uracil-sensing domain For the structural analysis of uracil-sensing domain, PDB ID, 2JGU and IWNS were used. A hypoxantine was snugly docked into into the binding pocket in the uracil-sensing domain using the "solid docking" module in QUANTA (Molecular Simulation, Inc.). The program considers an electrostatic and geometric complementarity in docking a guest molecule into a host molecule.
  • dITP inhibits PCR amplification of family B-type DNA polymerases It was found that PCR amplification of family B-type DNA polymerases from hyperthermophilic archaea was significantly inhibited by dITP whereas Taq, a family A- type DNA polymerase, was not (FIG. 6) . Biochemical and structural investigation of Pfu DNA polymerase to unveil the molecular basis for the inhibitory effect of dITP demonstrated that dITP was incorporated into newly synthesized strands in the iirst round of the PCR, and subsequently uracil-sensing domain would sense the incorporated hypoxanthine in the template, eventually stalling replication (FIG. 13, FIG. 14 and FIG. 15) .
  • Pfu, KODl and TNAl polymerases could replicate the template, indicating that the polymerase activity of Pfu, KODl and TNAl polymerases was not inhibited by dITP (FIG. 13) .
  • dITP dITP
  • Pfu DNA polymerase stopped right after adding a hypoxanthine to pair with cytosine. It is known that the paring with cytosine is the most stable even though hypoxanthine can pair with all four natural bases.
  • KODl and TNAl DNA polymerases could replicate the template up to the end (44-mer) using only dITP as a sole dNTP. It was thought that KODl and TNAl DNA polymerases were relatively insensitive to the wobble base pairing between hypoxanthine and other bases while Pfu DNA polymerase extremely prefers hypoxanthine and cytosine base-paring. Regardless of the disparity in the incorporation pattern, it was obvious that DNA polymerase activity itself was not affected by the presence of dITP.
  • primer extension assay was performed to test whether the presence of hypoxanthine in the DNA template was a cause for the inhibitory effect of dITP.
  • Pfu DNA polymerase was stalled at a DNA template with hypoxanthine, similar to stalling at uracil, raising the possibility that Pfu DNA polymerase can sense hypoxanthine in the DNA template.
  • structural and biochemical analysis was performed as followed.
  • uracil-sensing domain of the DNA polymerase was responsible for recognizing hypoxanthine in that mutations at critical residues (Y7, V93, and F116) in uracil-sensing domain could get over the stalling in the presence of hypoxanthine (FIG. 14), consistent with the recent report (Gill S. et al . , 2007, J MoI Biol) .
  • Molecular docking model supports the finding that hypoxanthine was well fitted to uracil sensing domain (FIG. 15) .
  • the docking with uracil may be the most favorable than other bases with less free energy, however, the hole could hold hypoxanthine as well .
  • dITP seemed to be incorporated in the first round of PCR, and then sensed by uracil-sensing domain, stalling DNA polymerases at the encountering hypoxanthine. Consistent with the observation with, family B-type DNA polymerases were also stalled in the presence of xanthine. However, the stalling position at xanthine was different (FIG. 16) .
  • chimeric proteins generated by whole domain swapping of uracil-sensing domains or exonuclease domains between Pfu and TNAl DNA polymerases exhibited similar stalling patterns to the corresponding wild type proteins.
  • a fusion protein with the uracil-sensing domain from Pfu DNA polymerase and the exonuclease/polymerase domain from NAl followed the pattern of TNAl DNA polymerase and vice versa (FIG. 10) . Consequently, it is reasonable to conclude that the discrepancy in the stalling pattern was neither brought about by uracil-sensing domain nor exonuclease domain.
  • TNAl and KODl DNA polymerases are superior to other DNA polymerases in extension rates.
  • TNAl and KODl DNA polymerase has three times and six times higher extension rate than Pfu and Deep-Vent DNA polymerases, respectively.
  • TNAl and KODl DNA polymerases were stalled at as low as 45 °C by a single deaminated base, but the stalling disappeared at higher temperatures (FIG. 11) .
  • TNAl DNA polymerase with three times higher extension rate than the wild type protein.
  • two successive deaminated bases were not enough to stall the mutant protein.
  • the result converges to support the close correlation between the stalling pattern and the extension rate.
  • the reason why the binding of the first deaminated base to uracil-sensing domain fails to stall TNAl and KODl polymerases would be that the binding energy was not enough to stall the fast- moving enzyme.
  • the interaction between the first deaminate base and the uracil-sensing domain could play as a brake to retard the enzyme, and subsequently, the DNA polymerase with a decreased mobility is then stalled by the second deaminated base.
  • This stalling mechanism of DNA polymerases may explain why DNA polymerases with higher extension rate require more deaminated bases to be stalled.
  • the binding of uracil (hypoxantine) to uracil- sensing domain which commonly occurs in family B-type DNA polymerases, does not necessarily lead to the stalling of enzymes. The stalling is highly likely to be determined by both the extension rate of DNA polymerase and the recognition of deaminated bases .
  • DNA polymerase works in concert with various auxiliary factors such as PCNA, replication factor, helicase and so on. It is possible that the factors or the condition in vivo could change the micro-environment of the enzyme, enable the DNA polymerases to sense even one base.
  • PCR conditions are as follows: 0.10 mM dATP cycled alone or with 5.00 ng ⁇ l-1 native dITPase. - Twenty five cycles: 95 0 C for 1 min, 95 0 C for 20 s, 72 0 C for 8 min, 72 0 C for 7 min.
  • TNA1__HAM1 A HAMl-like protein homologue (TNA1__HAM1) from Thermococcus onnurineus NAl was cloned and expressed in E. coli. TNA1_HAM1 showed similarities to HAMl-like protein from Thermococcus sp.
  • the purified TNA1_HAM1 could eliminate the generated dITP during PCR amplification, and enhanced PCR amplification yield by TNAl and Pfu DNA polymerases (FIG. 12) .
  • the characterization of purified HAMIp Choung JH et al., 2001, Nucleic Acids Res 29:3099- 3107) and dUTPase (Hogrefe HH et al., 2001, Proc Natl Acad Sci USA 99:596-601., Cho Y et al., 2007, Mar Blotechnol (In press) ) showed that the two enzymes are very specific to hypoxanthine/xanthine and uracil dNTP, respectively.
  • PCR yield by adding TNA1_HAM1 may be cumulative effects of hydrolyzing dITP and dXTP, considering that dGTP deamination could take place.
  • the recognition (sensing) of deaminated bases is an intrinsic property of family B-type DNA polymerases of hyperthermophilic archaea living at temperatures above 80 0 C, preventing transition mutation of deaminated bases.
  • the stalling of DNA polymerase seems to rely on the molecular mobility during DNA replication.
  • dITPase is a strategic, effective way to escape the inhibitory effect of dITP or dXTP in the PCR.
  • the effects of pH on the nucleotide hydrolysis activities of dITPase were analyzed under various pH conditions with the substrate dITP (FIG. 17) .
  • the nucleotide hydrolysis activity of dITPase has alkaline pH.
  • the reaction rates under neutraL conditions were ⁇ 10% of maximum (FIG. 17).
  • Dependence of the nucleotide hydrolysis activities of dITPase on temperature was also investigated.
  • the optimal reaction temperature of dITPase was 70 ° C, but the activities was greatly reduced above 90 ° C (FIG. 17) .
  • reaction for dUTPase was carried out in 50 ⁇ l of reaction mixture containing lxTris-HCl buffer (120 mM Tri-HCl, 1 mM
  • reaction mixture 50 ⁇ l contains 100 mM dATP and lxBuffer (120 mM Tris-HCl, 1 mM MgCl 2 , 60 mM KCl, 30 mM (NH 4 ) 2 SO 4 , and 0.01% BSA), and was analyzed after 12 kb- targeted PCR reaction. Thermal condition is same as PCR condition.
  • dITPase 5 ng was used as a same time to check its effect on removing by-product (dITP) .
  • the reaction products were chromatographed on Partisil-10 SAX column
  • the amount of dITP, which is produced during PCR reaction, has been carried out by HPLC.
  • the peak expected to dITP was detected at 7.7-7.9 min and it was removed when dITPase was added to PCR mixture. It was observed that 0.93% of dATP was converted to dITP during PCR reaction (Table 4) .
  • dITPase and dUTPase were added to amplifications of 2, 5, 8, 10, and 12 kb lambda DNA targets conducted with cloned TNAl DNA polymerase (20 ng) , using extension time (2, 3.5, 5, 6, and 7 min) . Enhancing activity was identified by a visible increase in product yield.
  • Two step reaction was used to amplify each DNA fragment under following conditions: an initial denaturation step of 1 min at 95 0 C, 25 cycles of amplification (20 s at 95°C, 2, 3.5, 5, 6, and 7 min at 72 0 C), and a final extension period of 5 min at 72 0 C.
  • Oxcidative deamination of DNA primarily convertes DNA base amino groups to keto groups. Thus, adenine is converted to hypoxanthine (HX) , guanine to xanthine (X) , and cytosine to uracil (U) . Also, a decrease in the activities of DNA polymerase, which is belonging to Family type B (TNAl, Pfu, and KOD) seemed to be slightly reduced by dITP and dUTP (Kim et al . , 2007, unpublished data). They are produced by deamination of DNA base amino group under high temperature condition followed by a decrease in product yield.
  • dITPase according to the present invention could be used for reactions of DNA amplification which was demanded for high sensitivity and rapidity, as supporting DNA polymerase activity.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne une dITPase, protéine permettant de renforcer l'activité d'ADN polymérase, et des gènes la codant. Plus particulièrement, l'invention concerne une ITPase isolée de la souche Thermococcus sp NAl. L'invention concerne également des fragments géniques codant ladite protéine, leurs vecteurs recombinants les contenant, leurs cellules hôtes transformées et des procédés de production dITPase au moyen desdites cellules hôtes.
PCT/KR2007/006150 2006-11-30 2007-11-30 Ditpase et gènes le codant WO2008066350A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020060119613A KR100825279B1 (ko) 2006-11-30 2006-11-30 Ｄｎα 중합효소 활성 증가 단백질 및 이를 암호화 하는유전자
KR10-2006-0119613 2006-11-30

Publications (1)

Publication Number Publication Date
WO2008066350A1 true WO2008066350A1 (fr) 2008-06-05

Family

ID=39468084

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2007/006150 WO2008066350A1 (fr) 2006-11-30 2007-11-30 Ditpase et gènes le codant

Country Status (2)

Country Link
KR (1) KR100825279B1 (fr)
WO (1) WO2008066350A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101142950B1 (ko) 2008-12-05 2012-05-08 성균관대학교산학협력단 써모코커스 마리너스 균주 유래의 내열성 ｄｎａ 중합효소 및 이의 이용

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054301A (en) * 1995-05-31 2000-04-25 Toyo Boseki Kabushiki Kaisha Methods of amplification using a thermostable DNA polymerase from the hyperthermophilic archaeon strain KOD1 and reagent kit therefor
US20040002076A1 (en) * 2001-11-28 2004-01-01 Mj Bioworks Incorporated Methods of using improved polymerases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773258A (en) * 1995-08-25 1998-06-30 Roche Molecular Systems, Inc. Nucleic acid amplification using a reversibly inactivated thermostable enzyme
KR100777227B1 (ko) * 2005-10-08 2007-11-28 한국해양연구원 고호열성 ｄｎａ 중합효소 및 이의 제조방법

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054301A (en) * 1995-05-31 2000-04-25 Toyo Boseki Kabushiki Kaisha Methods of amplification using a thermostable DNA polymerase from the hyperthermophilic archaeon strain KOD1 and reagent kit therefor
US20040002076A1 (en) * 2001-11-28 2004-01-01 Mj Bioworks Incorporated Methods of using improved polymerases

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE GENPEPT [online] 2005, FUKUI T. ET AL.: "Complete genome sequence of the hyperthermophilic archaeon Thermococcus kodakaraensis KOD1 and comparison with Pyrococcus genomes", Database accession no. (BAD86300) *
DATABASE GENPEPT [online] 7 May 2003 (2003-05-07), "HAM1-like protein [Thermococcus sp. OGL-20P] length 184aa", Database accession no. (AAP45001) *
GRIFFITHS K. ET AL.: "New high fidelity polymerases from Thermococcus species", PROTEIN EXPR. PURIF., vol. 52, no. 1, pages 19 - 30, XP005758602, DOI: doi:10.1016/j.pep.2006.07.022 *
IMANAKA T. ET AL.: "Catalyzing "hot" reactions: enzymes from hyperthermophilic Archaea", CHEM. REC., vol. 2, no. 3, 2002, pages 149 - 163, XP002475086, DOI: doi:10.1002/tcr.10023 *
KIM Y.J. ET AL.: "Cloning, purification, and characterization of a new DNA polymerase from a hyperthermophilic archaeon, Thermococcus sp. NA1", J. MICROBIOL. BIOTECHNOL., vol. 17, no. 7, July 2007 (2007-07-01), pages 1090 - 1097, XP002549344 *
KONG H. ET AL.: "Characterization of a DNA polymerase from the hyperthermophile archaea Thermococcus litoralis. Vent DNA polymerase, steady state kinetics, thermal stability, processivity, strand displacement, and exonuclease activities", J. BIOL. CHEM., vol. 268, no. 3, 25 January 1993 (1993-01-25), pages 1965 - 1975, XP000611227 *
KUROITA T. ET AL.: "Structural mechanism for coordination of proofreading and polymerase activities in archaeal DNA polymerases", J. MOL. BIOL., vol. 351, no. 2, 12 August 2005 (2005-08-12), pages 291 - 298, XP004979567, DOI: doi:10.1016/j.jmb.2005.06.015 *

Also Published As

Publication number Publication date
KR100825279B1 (ko) 2008-04-25

Similar Documents

Publication Publication Date Title
KR19990076834A (ko) 신규 dna 폴리머라제
JP5394928B2 (ja) サーマス・エガートソニイ（ｔｈｅｒｍｕｓｅｇｇｅｒｔｓｓｏｎｉｉ）ｄｎａポリメラーゼ
US8257953B2 (en) Hyperthermophilic DNA polymerase and methods of preparation thereof
KR101721396B1 (ko) 향상된 전환 활성을 가지는 l-아라비노스 이성화효소 변이체 및 이를 이용한 d-타가토스의 생산 방법
Cambon-Bonavita et al. Cloning, expression, and characterization of DNA polymerase I from the hyperthermophilic archaea Thermococcus fumicolans
US20100297706A1 (en) Mutant dna polymerases and their genes from thermococcus
JP5617075B2 (ja) 酵素
US20110020896A1 (en) Mutant dna polymerases and their genes
WO2008066350A1 (fr) Ditpase et gènes le codant
KR101105271B1 (ko) 돌연변이 나노아케움 이퀴탄스 ａ５２３ｒ ｄｎａ 중합효소 및 이의 이용
JP4714848B2 (ja) Ｄｎａポリメラーゼ変異体
KR101142950B1 (ko) 써모코커스 마리너스 균주 유래의 내열성 ｄｎａ 중합효소 및 이의 이용
KR100777228B1 (ko) 고호열성 디유티피아제 및 이의 제조방법
KR100969477B1 (ko) 써모코커스 구아이마센시스 균주 유래 내열성 ｄｎａ중합효소 및 이를 이용한 중합효소 연쇄반응 방법
Kim et al. Characterization of a dITPase from the hyperthermophilic archaeon Thermococcus onnurineus NA1 and its application in PCR amplification
KR100774102B1 (ko) 썰포포보코커스 질리지 유래의 내열성 ｄｎａ 연결효소
WO2024262588A1 (fr) Procédé de réduction de biais d'amplification dans une amplification d'acide nucléique
KR20100107873A (ko) 써모코커스 씰러 균주 유래의 내열성 ｄｎａ 중합효소 및 이의 이용
KR20070039447A (ko) 고호열성 리가아제 효소 및 이의 제조방법
KR20100060283A (ko) 신규한 내열성 ｄｎａ 중합효소
KR20110103750A (ko) 써모코커스 래디오톨러런스 균주 유래의 내열성 ｄｎａ 중합효소 및 이의 이용
JPH1132773A (ja) 耐熱性グリセロールキナーゼ及びそれをコードするｄｎａ

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07851167

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07851167

Country of ref document: EP

Kind code of ref document: A1